Blood Cancer
44
15
17
17
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
2.3%
1 terminated out of 44 trials
94.4%
+7.9% vs benchmark
0%
0 trials in Phase 3/4
41%
7 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (44)
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation
A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut
Immune Profiling for Cancer Immunotherapy Response
Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years
Resiliency in Older Adults Undergoing Bone Marrow Transplant
Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy.
Enhanced Assistance During Radiotherapy for Unmet Essential Needs
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention
Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant.
Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer
Better Leukemia Diagnostics Through AI (BELUGA)
MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies